Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560246 · ClinicalTrials.gov registry record
Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 400
- Enrollment target
NCT02560246: Completed study, sponsored by University of Pennsylvania.
NCT02560246 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02560246 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether diet and the gut microbiome play a role in spontaneous preterm birth (SPTB), namely delivery of the fetus prior to 37 weeks gestation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2015-05-04 |
| Est. Completion | 2017-08-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02560246
The ClinicalTrials.gov registry entry for NCT02560246 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02560246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02560246 about?
NCT02560246 is a clinical study titled "Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth". The purpose of this study is to determine whether diet and the gut microbiome play a role in spontaneous preterm birth (SPTB), namely delivery of the fetus prior to 37 weeks gestation.
What is the current status of trial NCT02560246?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2015-05-04. Estimated completion is 2017-08-29.
Who is sponsoring clinical trial NCT02560246?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.